Ox­ford spin­out Evox grabs a $45M bankroll to ad­vance to the clin­ic with new ex­o­some tech

A group of sci­en­tists in­tent on hi­jack­ing ex­o­somes for ther­a­peu­tic pur­pos­es has gath­ered to­geth­er a $45.4 mil­lion round — in­clud­ing a sig­nif­i­cant con­tri­bu­tion from Google’s GV …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER